Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001731122-22-000002
Filing Date
2022-01-03
Accepted
2022-01-03 06:01:48
Documents
1
Period of Report
2021-12-27

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3733
  Complete submission text file 0001731122-22-000002.txt   5373
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Enochian Biosciences Inc (Issuer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TOBIRA THERAPEUTICS, INC. 701 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Brosgart Carol L (Reporting) CIK: 0001614724 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38758 | Film No.: 22500054